ArticleScientific reports2024

Author Correction: Modulation of tumor immune microenvironment by TAS-115, a multi-receptor tyrosine kinase inhibitor, promotes antitumor immunity and contributes anti-PD-1 antibody therapy.

Toshihiro Shibutani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.